ArticleLeukemia2026
Retroperitoneal bulk predicts chylothorax in follicular lymphoma-control requires systemic response.
Denis Terziev, Franziska Lea Schümann, Timo Behlendorf, Franziska Brunner, Stephan Eisenmann, Elisabeth Groß, Michael Heuser, Thomas Weber
Abstract readLetter
In one paragraphArticle in Leukemia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Denis Terziev *Department of Internal Medicine IV, Hematology and Oncology, Universitätsmedizin Halle (Saale), University Hospital Halle (Saale), Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.
Franziska Lea Schümann *Department of Internal Medicine IV, Hematology and Oncology, Universitätsmedizin Halle (Saale), University Hospital Halle (Saale), Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.
Timo BehlendorfOnkologie MVZ III der Evidia MVZ Halle (Saale) GmbH, Halle (Saale), Germany.
Franziska BrunnerDepartment of Internal Medicine IV, Hematology and Oncology, Universitätsmedizin Halle (Saale), University Hospital Halle (Saale), Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.
Stephan EisenmannDepartment of Internal Medicine I, Gastroenterology and Pulmology, Universitätsmedizin Halle (Saale), University Hospital Halle (Saale), Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.
Elisabeth GroßDepartment of Internal Medicine IV, Hematology and Oncology, Universitätsmedizin Halle (Saale), University Hospital Halle (Saale), Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.ORCID http://orcid.org/0000-0002-1506-9559 Michael HeuserDepartment of Internal Medicine IV, Hematology and Oncology, Universitätsmedizin Halle (Saale), University Hospital Halle (Saale), Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.ORCID http://orcid.org/0000-0001-5318-9044 Thomas WeberDepartment of Internal Medicine IV, Hematology and Oncology, Universitätsmedizin Halle (Saale), University Hospital Halle (Saale), Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany. thomas.weber@uk-halle.de.ORCID http://orcid.org/0000-0002-8724-9348 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Identifiers
PMID42410206
PMCPMC13506320
What OpenQuestion holds
Textmetadata
Read underepoch 390